Donor Recipient Chimeric Cells Induce Chimerism and Extend Survival of Vascularized Composite Allografts

This study evaluated the efficacy of donor recipient chimeric cell (DRCC) therapy created by fusion of donor and recipient derived bone marrow cells (BMC) in chimerism and tolerance induction in a rat vascularized composite allograft (VCA) model. Twenty-four VCA (groin flaps) from MHC-mismatched ACI...

Descripción completa

Detalles Bibliográficos
Autores principales: Cwykiel, Joanna, Jundzill, Arkadiusz, Klimczak, Aleksandra, Madajka-Niemeyer, Maria, Siemionow, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110509/
https://www.ncbi.nlm.nih.gov/pubmed/33970329
http://dx.doi.org/10.1007/s00005-021-00614-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110509/
https://www.ncbi.nlm.nih.gov/pubmed/33970329
http://dx.doi.org/10.1007/s00005-021-00614-9

Ejemplares similares